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ABSTRACT
The chromatin immunoprecipitation (ChIP) assay is
a major tool in the study of genomic processes
in vivo. This and other methods are revealing that
control of gene expression, cell division and DNA
repair involves multiple proteins and great number
of their modifications. ChIP assay is traditionally
done in test tubes limiting the ability to study
signaling of the complex genomic events. To
increase the throughput and to simplify the assay
we have developed a microplate-based ChIP (Matrix
ChIP) method, where all steps from immunoprecipi-
tation to DNA purification are done in microplate
wells without sample transfers. This platform has
several important advantages over the tube-based
assay including very simple sample handling, high
throughput, improved sensitivity and reproducibility,
and potential for automation. 96 ChIP measure-
ments including PCR can be done by one researcher
in one day. We illustrate the power of Matrix ChIP by
parallel profiling 80 different chromatin and tran-
scription time-course events along an inducible
gene including transient recruitment of kinases.
INTRODUCTION
Chromatin-dependent processes respond to extracellular
signals, and control gene transcription, cell division and
DNA repair (1–3). The dynamic chromatin structure is
at the center of regulating these nuclear events. ChIP has
proven to be a powerful tool to investigate chromatin
structure (1,4,5). Along with other techniques (6,7), ChIP
assays are revealing complexity of chromatin, tran-
scriptional, RNA processing and DNA replication
events (1,6,8–13). These processes are regulated by multi-
ple histone modiﬁcations mediated by kinases, methyl-
transferases, acetyltransferases, ubiquitintransferases and
others (14–19). Given that there are hundreds of diﬀerent
transcription and RNA processing factors, the list of
regulatory modiﬁcations of DNA-bound and accessory
factors is far greater than that documented for histones
alone. The ability to follow a multitude of these
modiﬁcation events simultaneously would enhance our
understanding of nuclear processes.
The traditional ChIP method has notable limitations, in
that it takes several days to complete, requires bead-based
immunoprecipitation, phenol-chloroform or spin column-
based DNA extractions and involves multiple tube
transfers (4). Such DNA extractions and precipitations,
are not only time consuming and tedious but also
introduce steps for potential sample loss, cross-
contamination and variability. This becomes a bigger
problem in experiments involving multiple chromatin
samples. We have previously developed the Fast ChIP
method that improved the standard ChIP protocol by
simplifying the DNA puriﬁcation step (20–23). Although
Fast ChIP increased the eﬃciency and reproducibility of
the procedure, it is done in test tubes and requires bead-
based precipitation and elution steps limiting the number
of samples that one researcher can handle and making it
unsuitable for automation.
This article describes a novel ChIP strategy, Matrix
ChIP, that utilizes surface-immobilized antibodies in a
96-well plate, where the entire procedure from chromatin
precipitation to PCR-ready DNA puriﬁcation is done
on the same plate without sample transfers. The high-
throughput potential of the Matrix ChIP is illustrated by
simultaneous proﬁling of recruitment of three kinases,
Erk1/2 (24), PKCd (25) and Fyn (26), and several
chromatin and transcriptional events along the PMA
inducible egr-1 locus in mesangial cells (27). These data
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recruitment to the inducible egr-1 gene resemble that of
RNA Polymerase II. We suggest that these kinases
phosphorylate their targets in situ to regulate chromatin
dynamics and transcription (28–32).
MATERIALS AND METHODS
96-wellmicroplates
Reactin-Bind
TM Protein A (Pierce cat. no. 15132) and
Polystyrene High Binding Capacity 96-well microplates
(Corning cat. no. 9018) were used.
Reagents
Chelex 100 (Bio-Rad, cat. no. 142-1253), Protein A
(Sigma, cat. no. P7837), Proteinase K (Invitrogen, cat.
no. 25530-015), Protein A–Sepharose (Amersham, cat. no.
17-5280-01), Formaldehyde (J.T. Baker, cat. no. 2106-02),
BSA (Sigma cat. No. A9647), beta-Glycerol phosphate
diSodium salt hydrate (Sigma cat. no. G-6251), Sodium
molybdate dihydrate (Sigma cat. no. S-6646), Sodium
ﬂuoride (Sigma cat. no. S-1504), Sodium orthovanadate
(Sigma cat. no. S-6508), p-nitrophenyl phosphate diTris
salt (Calbiochem cat. no. 487655), PMSF (Sigma, cat. no.
P-7626), Leupeptin (Sigma, cat. no. L-2884), SYBR Green
PCR Master Mix (Quantace, 2xSensiMix, cat. no. QT6T3)
and Salmon sperm DNA [Sigma, cat. no. D1626] were the
reagents used.
Equipment
ChIP: Misonix Sonicator 3000 with micro tip (Misonix,
cat. no. S3000); Ultrasonic bath (Branson, cat. no. B3510-
MT CPN-952-316); Heat blocks (Analog Heat Block
VWR Scientiﬁc 13259032, and Isotemp 125, Fisher
Scientiﬁc); Eppendorf Repeater Pipette model 4780.
PCR: Quantitative PCR ABI 7900HT system, ABI
Biotechnology; MixMate (Eppendorf).
Buffers
PBS: 137mM NaCl, 10mM Sodium phosphate, 2.7mM
KCl, pH 7.4; TE: 10mM Tris, 1mM EDTA, pH 7.5;
Immunoprecipitation (IP) buﬀer: 150mM NaCl, 50mM
Tris–HCl (pH 7.5), 5mM EDTA, NP-40 (0.5% vol/vol),
Triton X-100 (1.0% vol/vol); Blocking buﬀer: 5% BSA,
100mg/ml sheared salmon sperm DNA in IP buﬀer;
Elution buﬀer: 25mM Tris base, 1mM EDTA, (pH 9.8),
200mg/ml proteinase K. A stock solution of 500ml of Tris
base-EDTA buﬀer is prepared at a time and stored at
room temperature for at least four months. A 20mg/ml
proteinase K stock solution in water is stored at –208C.
Cells
Rat mesangial cells were grown in 150mm plastic cell
culture dishes in RPMI 1640 media supplemented with
10% FBS, 2mM glutamine, penicillin (100units/ml),
streptomycin (0.01%) and humidiﬁed with 5/95%
CO2/air gas mixture (33).
Preparation of sheared chromatin andtube-based Fast
ChIP assay
Preparation was done as described previously using IP
buﬀer containing protease and phosphatase inhibitors
(20,34). Sheared chromatin of 1ml was prepared from
1–2 10
7 mesangial cells and stored in 50ml aliquots
(–708C) to avoid repeated thawing/freezing.
Matrix ChIP assayusing polystyrene plates coated with
protein A
All washes were done using needle connected to vacuum
pump and Eppendorf Repeater Pipette. Polystyrene plates
washed once with 200ml PBS/well were incubated over-
night with 0.2mg Protein A in 100ml PBS/well. After a
wash (200ml PBS/well) well walls were blocked with 200ml
blocking buﬀer (15–60min, RT). Wells were cleared and
then incubated with antibodies in 100ml blocking buﬀer/
well (60min, RT). Wells were cleared and chromatin
samples (2.0–5.0ml chromatin prep/100ml blocking buﬀer)
were added to wells (100ml/well) and plates were ﬂoated in
ultrasonic water bath (60min, 48C) to accelerate protein–
antibody binding (20,34,35). Well walls were washed three
times with 200ml IP buﬀer and once with 200ml TE buﬀer.
Wells were incubated with 100ml elution buﬀer (15min at
558C, followed by 15min at 958C). DNA samples were
stored (–208C) in the same Matrix ChIP plates for
repeated use.
Real-time PCR
The reaction mixture contained 2.5ml 2X SYBR Green
PCR master mix (SensiMix, Quantace), 2.3ml DNA
template and 0.2ml primers (10mM) in 5ml ﬁnal volume
in 384-Well Optical Reaction Plate (Applied Biosystems).
Ampliﬁcation (three steps, 40 cycles), data acquisition and
analysis were carried out using the 7900HT Real Time
PCR system and SDS Enterprise Database (Applied
Biosystems). All PCR reactions were run in triplicates.
Calculations
ChIP DNA data were expressed as a fraction of input
DNA calculated using the following method. PCR
calibration curves were generated for each primer pair
from a dilution series of total cellular DNA. The PCR-
primer eﬃciency curve were ﬁt to the ln (Standard DNA
dilution) versus CT points measured for the DNA samples
using an R-squared best ﬁt. DNA concentration values for
each ChIP and input DNA samples were calculated from
their respective average PCR CT values using the formula
½DNA ¼
b   em AvgCT
Dilution
1
where b and m are the curve ﬁt parameters from the
primer calibration curve that is generated for each PCR
experiment. Dilution is the cumulative dilution of ChIP
DNA compared to input DNA sample. Final results are
expressed as
½ChIP DNA 
½Input DNA 
¼
½DNAsample  ½ DNAmock 
½DNAinput 
2
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Equation (1), DNAsample, ChIP DNA sample; DNAmock,
IgG mock IP control and DNAinput; input DNA used
in ChIP.
RESULTS AND DISCUSSION
Fast ChIP is done in test tubes with antibody immobilized
to protein A-agarose beads that require centrifugation and
use of Chelex-100 resin to purify the DNA (20). Our goal
was to develop a simple microplate-based ChIP method
that would not only increase the throughput but would
also be suitable for automation. The adaptation of the
Fast ChIP assay to a 96-well microplate format required
several key modiﬁcations: (i) Puriﬁcation of PCR-ready
DNA without Chelex-100 resin. (ii) Immobilization of
antibodies to well walls. (iii) Minimizing non-speciﬁc
adsorption to the well surface.
DNA purification
Isolation of PCR-ready DNA from immunoprecipitated
chromatin requires not only elution of the DNA from the
protein A agarose beads but also reversal of the cross-
links between DNA and proteins. In the Fast ChIP assay
we introduced Chelex-100 resin to extract DNA (20). For
the plate-based ChIP, we chose to develop a simpler
method for the isolation of PCR-ready DNA from the
surface-bound antibody by using a buﬀer that reverses
cross-links and facilitates DNA extraction.
The Chelex-100 resin is a styrene-divinylbenzene copo-
lymer containing paired iminodiacetate groups which
chelate polyvalent metal ions. The Chelex suspension
has pH  10. We reasoned that a high pH buﬀer and
EDTA could be substituted for the Chelex beads. The test-
tube format with chromatin-loaded Protein A beads was
used to test buﬀers with a range of pH values. The Chelex-
based Fast ChIP protocol was used as a positive control
(20). Brieﬂy, test tubes with chromatin-loaded Protein A
beads (anti-H3K4m3 antibody) suspended in elution
buﬀer were ﬁrst incubated with proteinase K at 558C for
15min and then at 958C for another 10min. After centri-
fugation of the tubes, supernatant was collected and used
in real-time PCR to compare the DNA recoveries to the
Chelex-based Fast ChIP protocol. The results demon-
strated that 25mM Tris base, 1mM EDTA (pH9.8)
performs comparably to Chelex (Figure 1), Therefore,
we used this buﬀer in the following experiments.
Antibody immobilization
The 96-well microplate format requires the protein
capturing antibodies to be attached to the surface of the
microplate well wall. Antibody-coated microplates
have been widely used in multi-well enzyme-sensitive
immunosorbent assays (ELISA) (36) and in standard
co-immunoprecipitations (37). For immobilizing antibo-
dies, the surface needs to be modiﬁed to maintain the
antibodies in an active state and in the correct orientation.
It is known that speciﬁc orientation of antibodies increases
the binding capacity of target molecules up to 10-fold
compared to surfaces with random-oriented antibodies (38).
Several antibody immobilization methods have been
introduced to achieve this goal (38–42). Surface coating
with Protein A, G or A/G mixture is one way to increase
antibody-binding capacity of a surface (43,44).
To test this strategy, we utilized commercially available
polystyrene Protein A coated 96-well microplates (Pierce).
The Fast ChIP done in tubes in parallel was used as
a control. Results of these experiments done with
H3K4m3 antibody demonstrated that the performance
of well-attached antibodies was comparable to Fast
ChIP. However, the unspeciﬁc background signal (Mock
IP done with non-immune IgGs) was higher in Matrix
ChIP. We found that using blocking buﬀer that
contains BSA and sheared salmon sperm DNA reduced
the non-speciﬁc binding to polystyrene well walls
(Figure 2). The reason for higher background with high
concentration of salmon sperm DNA is not clear, it is
possible that excess of DNA causes aggregation of
chromatin to the well walls.
Although pre-coated Protein A microplates are
commercially available they are costly. We found that
passive adsorption of Protein A to the Corning
Polystyrene High Bind Microplate performed well in
the ChIP assay. Thus, Protein A-coated ChIP microplates
can be easily fabricated in the laboratory (‘Methods’
section).
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Figure 1. Extraction of PCR-ready DNA from immunoprecipitated
chromatin with Tris-base/EDTA buﬀer. All steps were done in 1.5ml
tubes. Sheared chromatin from MC (0.5ml) was incubated with anti-
H3K4m3 antibody in an ultrasonic water bath (15min, 48C). After
centrifugation (10min at 17000g) the supernatant was transferred to
fresh tubes containing Protein A agarose beads. The slurry was rotated
for 45min (48C) and then the beads were washed with IP buﬀer (20,34).
Equal aliquots of beads were ﬁrst incubated with proteinase K
(200mg/ml) in either 25mM Tris, 1mM EDTA (pH9.8, 8.6, 7.6 or
3.5 titrated with HCl) or 10% Chelex/H2O for 15min at 558C and then
at 958C for 15min. After centrifugation the supernatant was collected
and analyzed by qPCR using primers to either 50-ﬂanking intergenic
(-5kb to egr-1 transcription start site) or transcribed region (exon 1 of
egr-1). PCR results are shown as percent of the ChIP DNA extracted
with Chelex (mean SD, n=3).
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polystyrene plates is summarized in Figure 3. The entire
ChIP procedure is done in the same microplate well.
The PCR-ready ChIP samples are stored in the same
plates ( 208C) for repeated use. Starting with sheared
chromatin, 96 PCR-ready ChIP DNA samples can be
generated in 4–5h.
Verification ofMatrix ChIP assay
To validate the Matrix ChIP method, we proﬁled
several inducible changes along the phorbol 12-myristate
13-acetate (PMA)-inducible egr-1 (27) locus in rat
mesangial cells using the Matrix ChIP method and
compared it to the tube-based Fast ChIP method (20,34).
We used both the commercially available (Pierce) and in-
lab made Protein A-coated microplates. The following
aﬃnity-puriﬁed antibodies were used: to RNA polymerase
II, Pol II (45), histone H3 (15) hnRNP K protein (46) and
the tyrosine kinase Fyn (26) as well as whole antiserum to
histone H3 dimethylated at lysine 4, H3K4m2 (Figure 4).
The detailed information about antibodies that were used
in this article is included in Table S1. The list includes
mouse monoclonal and rabbit polyclonal that either
aﬃnity, or Protein A- and Protein G-puriﬁed antibodies
as well as whole antisera.
The Pol II, H3, H3K4m2 and hnRNP K (46) densities
at the egr-1 gene measured with the Matrix and Fast ChIP
assays were overall similar. While transient binding of Fyn
to the egr-1 gene was observed with Matrix ChIP, the level
of recruitment detected with Fast ChIP was much lower.
The reproducibility of the results obtained with the Matrix
ChIP method is illustrated by similar kinetics of changes
of Pol II, hnRNP K and Fyn at the egr-1 locus observed
in two independent experiments (Figure 4). Also, this
comparison shows that the in-lab coated and the
commercially available plates performed equally well.
Matrix ChIP enables tracking ofkinase binding in parallel
with manychromatin andtranscriptional events alongthe
transcribed gene locus
Extracellular stimuli activate signaling cascades that result
in changes of gene expression, cell division and other
processes. Protein kinase-mediated phosphorylation plays
a major role in signal transmission (47). In many cases
the steps required for signaling have been deﬁned.
Compartmentalization of protein kinases has been recog-
nized as an important mode to control events at discrete
intracellular locations (48–52). However, it was not until
very recently that inducible kinases were discovered to be
directly recruited to genomic sites (28–32). Most of these
studies were done in yeast and looked at a single kinase at
a time. MAPK, PKC and tyrosine kinase cascades are the
major pathways that signal inducible genomic events in
response to mitogens and other stimuli (31,32). We used a
panel of MAPK, PKC and tyrosine anti-kinase antibodies
in Matrix ChIP to identify which kinases target the
mitogen-inducible egr-1 locus. Among 18 anti-kinase
antibodies tested, this search identiﬁed strong recruitment
of active phospho Erk1/2 and PKCd as well as Fyn. We
used Matrix ChIP and 20 diﬀerent antibodies to correlate
recruitment of these kinases with chromatin and tran-
scription events (Figures 5 and S1). Pol II density is
highest at the transcription start sites (17,53,54). Parallel
proﬁling revealed that the kinetics of Erk1/2, PKCd and
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Figure 2. Reducing non-speciﬁc chromatin binding to well walls with
sheared salmon DNA (ssDNA). Polystyrene well walls were pre-
blocked with 5%BSA and either 0, 50, 100, 200, 400mg/ml of ssDNA.
After washing with IP/TE buﬀers DNA was eluted from the walls and
assayed in real-time PCR using primers to egr-1 exon1. PCR results are
shown as percent of chromatin DNA bound to walls without blocking
buﬀer (mean SD, n=3).
Blocking well walls 
15-60  min, 25°C 
rocking platform
Antibody immobilization 
60 min, 25°C 
rocking platform
Chromatin binding 
60 min 4°C 
sonication bath
Well wash 
3x 200ml IP buffer 
1x 200ml TE
DNA elution 
15 min 55°C 
15 min 95°C
96 DNA PCR-ready samples
Protein A coated 
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Figure 3. Diagram of the Matrix ChIP protocol. Detailed protocol is
described in ‘Methods’ Section. Starting with sheared chromatin and
Protein A coated plates 96 ChIPs can be completed in 4–5h.
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spatiotemporal patterns of Pol II, hnRNP K (46) and
HP1g (55) recruitment. Higher spatiotemporal resolution
is needed to determine if these proﬁles are identical.
HnRNP K acts as a docking platform at sites of nucleic-
acids-directed processes (46,56,57). HnRNP K may bind
pre-mRNA and/or Pol II. Since hnRNP K interacts with
Erk1/2, PKCd and Fyn (46) it may serve to recruit and/or
regulate activity of these enzymes along the egr-1 locus.
Several chromatin factors have recently been shown to be
associated with transcription including HP1g (55). It has
been suggested that HP1 proteins may provide a dynamic
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Figure 4. Validation of Matrix ChIP assay. Sheared chromatin was prepared from PMA-treated rat mesangial cells. Matrix ChIP method using
either in-lab (Plate 1) or commercial (Pierce) (Plate 2) Protein A-coated polystyrene plates was compared to tube-based Fast ChIP assay (20). The
following rabbit polyclonal antibodies were used; anti-Pol II (N20), anti-hnRNP K, anti-Fyn (FYN3), anti-histone H3 and whole antiserum,
anti-H3K4m2 (Table S1). Real-time PCR was done using primers to either egr-1 exon 1 (+232bp from transcription start site, TSS) or 50 ﬂanking
site (-5344bp from TSS), -5kb. Non-immune IgG fraction was used as a mock IP control. ChIP results are calculated as fraction of input DNA
(see ‘Methods’ Section).
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The full data set (20 diﬀerent antibodies) is shown in Figure S1.
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Thus, HP-1g may serve to transmit kinase signals to
chromatin and/or to recruit these enzymes. It is also
possible that recruited kinases are activated in situ and
transmit signals downstream by phosphorylating compo-
nents of chromatin components and transcriptional
machinery.
The constitutive and inducible proﬁles of chromatin
factors and histone marks observed at the egr-1 promoter
and the transcribed region (Figures 5 and S1) are in good
agreement with the general patterns seen along transcribed
genes (17,53,54). For example, lower nucleosome density
in regions ﬂanking transcription start sites is a common
feature of genes (14,53). We found that total histone H3
levels and several of its marks were lowest at the promoter
of transcribed egr-1 gene (Figure 5). Acetylation of lysines
eliminates their positive charge which, when it occurs on
certain histone tails, has been shown to have a negative
eﬀect on the higher order structure of chromatin,
essentially making it more open (15). In agreement with
previous reports we found inducible changes in histone H3
and H4 acetylation (59). Di- and trimethylation of histone
H3 lysine 4, H3K4m2/m3, are associated with actively
transcribed genes (60–62). Consistent with previous
reports, H3K4m2 and m3 marks were enriched in the
egr-1 transcribed region and there was a decrease with
induction. As there was no change in total H3 levels this
decrease could reﬂect demethylation or histone exchange
(2,63). Trimethylation of histone H3 lysine 36, H3K36m3,
is a mark associated with transcription elongation (15,64).
H3K36m3 levels were lowest at the promoter and highest
in the transcribed region, this pattern of H3K36 methyla-
tion, is a common feature of transcribed genes (18,54).
Trimethylation of lysine 27 of histone H3, H3K27m3, is a
marker of silent genes (60). In agreement with previous
studies on H3K27 methylation (54,65,66), the level of
H3K27m3 was signiﬁcantly higher within the 50 ﬂanking
region (Figure S1).
Serum responsive factor (SRF) binds several elements
within the egr-1 promoter (67–69). Matrix ChIP revealed
SRF presence in the promoter region in uninduced cells
and following induction its levels decreased (Figure 5).
The signiﬁcance of the decrease remains to be determined.
The coupled chromatin, transcription and RNA proces-
sing and other genome-directed events have emerged as
some of the most intensively studied ﬁelds of biology
today (15,16,18,70). Matrix ChIP introduces the much
needed high-throughput technology to eﬀectively use the
large collection of antibody probes. With these advances,
the Matrix ChIP platform enables us for the ﬁrst time to
follow hundreds of antigens including the less abundant
but critical factors such as kinases (Figures 5 and S1).
Thus, the Matrix ChIP platform greatly increases the
potential to study the complexity of the inducible and
dynamic chromatin, transcription and RNA-processing
events. Studies of this type also promise to facilitate
discovery of epigenetic biomarkers of diseases.
In summary, we have developed a microplate-based
ChIP technology that has several important advantages
over the test-tube-based assay. (i) The entire procedure is
done on the same plate without sample transfers, which
simpliﬁes the procedure, increases sample to sample
measurement consistency, reduces the time of the assay
and reduces sample loss. (ii) Increased throughput allows
for eﬃcient sample processing so that one can run 96 or
more ChIPs followed by PCR analysis in one day. (iii)
Microplate Matrix ChIP could be automated for studies
to follow complex chromatin and transcriptional events or
high volume screening applications.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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